Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Glivec in Unresectable or Metastatic Malignant GIST
NCT00293124Phase 3Completed
- Sponsor
- Central European Cooperative Oncology Group
- Start
- Mar 2004
- Primary completion
- Jul 2006
- Modality
- Small Molecules
- Countries
- 10
01
Overview
A Phase 3 trial of imatinib in gastrointestinal stromal tumor (GIST), sponsored by Central European Cooperative Oncology Group. Started Mar 2004; status: completed.
02
Drugs
03
Conditions
gastrointestinal stromal tumor (GIST)
Beyond the preview
Go deeper on NCT00293124.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00293124.